GMP IPO
📋 Filings Intelligence
About Contact
LIVE - Auto-updated every 10 mins · Equity segment
Company Filings, Explained Simply

AI-powered plain-English analysis of every important corporate announcement - financial results, order wins, dividends, mergers and more. Updated live.

-
Filed today
-
Companies tracked
NSE & BSE
Listed on
Sign in free to search by company
Filing Type
Market Cap
Sector
All Sectors

Latest Filings -

📋 Filing Types Available on ForgeUp Filings Sourced from BSE corporate announcements (equity segment). Companies covered are BSE-listed and most are also listed on NSE. We show only material filings.
Financial Results Orders Dividend Buyback Merger / Acquisition Board Meeting Outcome Fundraise (QIP / Rights / FPO) Regulatory / Court Order Credit Rating Change Promoter Pledge Update Management Change Joint Venture / MOU Delisting Bonus Shares Stock Split
Data sourced from BSE India corporate announcements. More categories will be added over time.
Sanofi India Ltd

Sanofi India Ltd: GST Show Cause Notice Dropped, Rs. 23.73 Crore Liability Resolved

REGULATORY ▲ Positive Development LOW RISK
📅 Filed on BSE: 17 Nov 2026, 06:50 PM IST  ·  BSE ID: 10a55c4b-1cb9-4120-aabd-23f796b129f2
View Original BSE Filing (PDF)
💡
In Simple Terms
Sanofi India settled a tax notice for Rs. 17,680, dropping a Rs. 23.73 Crore claim for improper tax credits.
🤖 AI Summary
  • Sanofi India's Rs. 23,73,76,507 GST liability notice is dropped.
  • Company paid Rs. 10,128 tax and Rs. 7,552 interest, total Rs. 17,680.
  • Proceedings concluded by Commercial Tax Officer regarding April 2022-March 2023 period.
  • No material impact on financial or operational activities reported.
🔢 Key Numbers - exact figures from BSE filing, not rounded
Proposed Tax Liability in Show Cause Notice
Rs. 23,73,76,507/-
Tax Paid
Rs. 10,128/-
Interest Paid
Rs.7,552/-
Total Amount Paid
Rs.17,680/-
Period Covered
April 2022 to March 2023
🏢 How This Affects the Company
💰
Financial Impact
The company has concluded a tax proceeding that initially proposed a liability of Rs. 23,73,76,507. The final settlement of Rs. 17,680 resolves this matter without significant financial strain.
⚠️
Risk Impact
This development resolves a previously disclosed tax risk concerning input tax credit for the April 2022 to March 2023 period.
👥 What This Means For Shareholders
✅
Action Required
No action is required from shareholders.
👤
Who Is Affected
All shareholders are informed of the resolution of a tax matter that had a proposed liability of Rs. 23,73,76,507.
🔍
Management Signal
Management's proactive engagement and representation successfully led to the dropping of a substantial GST notice.

For information only. Not investment advice. ForgeUp is not SEBI-registered.

👁 Watch List - track these upcoming events
Company's next quarterly results for updated financial performance.
Future tax filings for any new disclosures.
Confirmation of no further claims related to this matter.
LOW RISK Tax notice dropped with minimal payment, confirming no material financial impact.
💡 Investor Takeaway
Sanofi India's GST proceedings for excess input tax credit, initially proposing Rs. 23,73,76,507, have concluded upon payment of Rs. 17,680. No material financial impact is reported.
⚖️ Strengths & Concerns

✅ Positives

  • Resolution of a Rs. 23.73 Crore GST notice with minimal payment of Rs. 17,680.
  • Confirms no material financial or operational impact from the concluded GST proceedings.
📅 Company Track Record
Sanofi India has previously seen tax demands dropped (Rs. 72,71,510 and Rs. 10,56,954) and others rejected (Rs. 11,62,853). This filing continues a trend of successfully contesting tax authorities' claims.

Based on publicly available historical data. For context only.

❓ Frequently Asked Questions
What was the total GST liability proposed against Sanofi India?
The Commercial Tax Officer proposed a tax liability of Rs. 23,73,76,507/-.
How much did Sanofi India pay to resolve the GST notice?
Sanofi India paid Rs. 10,128/- in tax and Rs. 7,552/- in interest, aggregating to Rs. 17,680/-.
What period did the GST Show Cause Notice cover?
The Show Cause Notice alleged excess Input Tax Credit for the period April 2022 to March 2023.
What is the impact of this GST resolution on Sanofi India's finances?
There is no material impact on the financial, operational, or other activities of the company.

Questions based on this BSE filing only. For information purposes.

You've read one filing

There are 32,000 more, and one of them is about a company you own

Follow a company and we'll email you the moment it files again - explained, not just forwarded. Free.

  • Follow companies and get filings by email
  • Save any filing to read later
  • Two full AI analyses free when you sign up

No card needed. Sign in with Google in two taps.

⚠️ For Information Only - Not Investment Advice
ForgeUp Filings provides AI-generated summaries of public BSE exchange announcements (equity segment) for informational purposes only. Nothing here constitutes investment advice or a recommendation to buy, sell, or hold any security. ForgeUp is not a SEBI-registered investment advisor. All financial numbers are sourced directly from BSE filings and shown as-is. Past data is historical only. Please consult a qualified financial advisor before making investment decisions. Data sourced from BSE India public disclosures.
🔍
Sign in to use filters
Sign in free with Google to filter filings by category, market cap and sector - takes 5 seconds.

Live IPO, GMP and market updates on Telegram

IPO open and close dates, grey market premium moves, subscription figures, allotment and listing days, and the market updates worth knowing about, posted on the channel as they happen.

Join the channel